Paper17537855
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
Lavillette D and 8 others. J Virol, 2007. Cited by 145 papers, by iCite.
Cite this record
ConductScience Library. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. Papers, record 17537855. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17537855
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepacivirus | Major topic |
| Membrane Fusion | Major topic |
| Viral Envelope Proteins | Major topic |
| Virion | Major topic |
| Amino Acid Sequence | |
| Humans | |
| Molecular Sequence Data | |
| Mutation |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15956584 | Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. | J Virol | 2005 | https://conductscience.org/library/papers/15956584 | PubMed |
| 2 | 16941688 | Hepatitis C virus entry: molecular biology and clinical implications. | Hepatology | 2006 | https://conductscience.org/library/papers/16941688 | PubMed |
| 3 | 10861927 | A model for the hepatitis C virus envelope glycoprotein E2. | Proteins | 2000 | https://conductscience.org/library/papers/10861927 | PubMed |
| 4 | 11264358 | Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein. | J Virol | 2001 | https://conductscience.org/library/papers/11264358 | PubMed |
| 5 | 11287576 | Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. | J Virol | 2001 | https://conductscience.org/library/papers/11287576 | PubMed |
| 6 | 11356980 | Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. | J Virol | 2001 | https://conductscience.org/library/papers/11356980 | PubMed |
| 7 | 11457993 | Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. | J Gen Virol | 2001 | https://conductscience.org/library/papers/11457993 | PubMed |
| 8 | 11514735 | Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity. | J Gen Virol | 2001 | https://conductscience.org/library/papers/11514735 | PubMed |
| 9 | 11602769 | Biogenesis of hepatitis C virus envelope glycoproteins. | J Gen Virol | 2001 | https://conductscience.org/library/papers/11602769 | PubMed |
| 10 | 12355096 | A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. | Nat Biotechnol | 2002 | https://conductscience.org/library/papers/12355096 | PubMed |
| 11 | 12615904 | Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. | J Exp Med | 2003 | https://conductscience.org/library/papers/12615904 | PubMed |
| 12 | 12667795 | Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. | Virology | 2003 | https://conductscience.org/library/papers/12667795 | PubMed |
| 13 | 12761383 | Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12761383 | PubMed |
| 14 | 12832074 | Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. | FEBS Lett | 2003 | https://conductscience.org/library/papers/12832074 | PubMed |
| 15 | 12873764 | The HIV Env-mediated fusion reaction. | Biochim Biophys Acta | 2003 | https://conductscience.org/library/papers/12873764 | PubMed |
| 16 | 12873772 | Fusion peptides and the mechanism of viral fusion. | Biochim Biophys Acta | 2003 | https://conductscience.org/library/papers/12873772 | PubMed |
| 17 | 12873773 | Viral fusion proteins: multiple regions contribute to membrane fusion. | Biochim Biophys Acta | 2003 | https://conductscience.org/library/papers/12873773 | PubMed |
| 18 | 12970403 | Herpesvirus entry: an update. | J Virol | 2003 | https://conductscience.org/library/papers/12970403 | PubMed |
| 19 | 12913001 | Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12913001 | PubMed |
| 20 | 14737160 | Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. | Nature | 2004 | https://conductscience.org/library/papers/14737160 | PubMed |
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 145 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41939904 | Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939904 | PubMed |
| 40099186 | Respiratory syncytial virus fuses with plasma membrane to infect primary cultures of bronchial epithelial cells. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40099186 | PubMed |
| 39232163 | The hepatitis C virus envelope protein complex is a dimer of heterodimers. | Nature | 2024 | https://conductscience.org/library/papers/39232163 | PubMed |
| 37432947 | Structures of the Hepaci-, Pegi-, and Pestiviruses envelope proteins suggest a novel membrane fusion mechanism. | PLoS Biol | 2023 | https://conductscience.org/library/papers/37432947 | PubMed |
| 36830808 | Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. | Biomedicines | 2023 | https://conductscience.org/library/papers/36830808 | PubMed |
| 36298858 | Host Cell Receptors Implicated in the Cellular Tropism of BVDV. | Viruses | 2022 | https://conductscience.org/library/papers/36298858 | PubMed |
| 35613596 | Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening. | Cell Rep | 2022 | https://conductscience.org/library/papers/35613596 | PubMed |
| 34793197 | Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies. | Science | 2022 | https://conductscience.org/library/papers/34793197 | PubMed |
| 34497798 | Identification and Characteristics of Fusion Peptides Derived From Enveloped Viruses. | Front Chem | 2021 | https://conductscience.org/library/papers/34497798 | PubMed |
| 34197186 | Small-Molecule Inhibition of Viral Fusion Glycoproteins. | Annu Rev Virol | 2021 | https://conductscience.org/library/papers/34197186 | PubMed |
| 34190687 | A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process. | Elife | 2021 | https://conductscience.org/library/papers/34190687 | PubMed |
| 33946211 | To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity. | Viruses | 2021 | https://conductscience.org/library/papers/33946211 | PubMed |
| 33925362 | Hepatitis C Virus Uses Host Lipids to Its Own Advantage. | Metabolites | 2021 | https://conductscience.org/library/papers/33925362 | PubMed |
| 33147126 | Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins. | J Gen Virol | 2021 | https://conductscience.org/library/papers/33147126 | PubMed |
| 32764419 | Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32764419 | PubMed |
| 32197477 | Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32197477 | PubMed |
| 31427285 | Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion. | Cold Spring Harb Perspect Med | 2020 | https://conductscience.org/library/papers/31427285 | PubMed |
| 30697280 | Development of Preventive Vaccines for Hepatitis C Virus E1/E2 Protein. | Iran J Pathol | 2018 | https://conductscience.org/library/papers/30697280 | PubMed |
| 30068644 | Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain. | J Virol | 2018 | https://conductscience.org/library/papers/30068644 | PubMed |
| 29971069 | Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. | Front Immunol | 2018 | https://conductscience.org/library/papers/29971069 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17537855
GET https://conductscience.org/api/papers/v1/17537855/references?page=2